Time-Restricted Eating Lowers HbA1c in Type 1 Diabetes Trial

Eight-Hour Eating Window Shows Blood Sugar Reductions

Limiting food intake to an eight-hour window improved blood sugar markers in adults living with both Type 1 diabetes and obesity. Researchers at the University of Illinois Chicago (UIC) evaluated this time-restricted eating protocol over a six-month randomized controlled trial. Participants who consumed their meals between noon and 8 p.m. achieved better glycemic results than those assigned to standard daily calorie restriction.

The trial enrolled 32 adults from the Chicago area and divided them into three distinct groups. One group practiced time-restricted eating without counting calories. A second group cut daily calorie intake by 25 percent, while a third control group maintained normal eating patterns.

Trial Results Show Glycemic Improvement and Stable Safety

Hemoglobin A1c (HbA1c) fell by an average of 0.5 percent in the time-restricted eating group over the six-month intervention. This blood marker reflects average blood glucose levels over the previous two to three months. The reduction surpassed the glycemic changes observed in the group assigned to standard 25 percent calorie restriction.

Safety monitoring revealed no elevated rates of dangerous acute events during the testing period. The research team recorded no increase in episodes of severe hypoglycemia or severe hyperglycemia. The protocol also produced no increase in diabetic ketoacidosis (DKA), an acute complication caused by insufficient insulin.

• Average HbA1c dropped by approximately 0.5 percent in the time-restricted eating cohort.
• Participants consumed all daily food between noon and 8 p.m. without mandatory calorie counting.
• Monitored rates of diabetic ketoacidosis and dangerous blood sugar swings remained stable.

Study Scope Focuses on a Specific Patient Group

The findings apply specifically to adults diagnosed with Type 1 diabetes who also meet the Centers for Disease Control and Prevention (CDC) definition for obesity based on body mass index (BMI). Lead author Krista Varady noted that this dual presentation accounts for roughly 0.5 percent of the total United States population. Type 1 diabetes occurs when the pancreas produces little or no insulin, affecting less than 1 percent of people nationwide.

The investigation was published in the medical journal Diabetes Care as a pilot exploration of intermittent fasting in this population. Because fasting intervals alter circulating glucose levels, insulin-dependent individuals face distinct risks that require close tracking. The authors stated that larger trials across multiple medical centers are required to confirm these outcomes across broader demographic groups.

Clinical Guidance Remains Necessary Before Dietary Shifts

The study authors emphasized that individuals with Type 1 diabetes should not adopt fasting schedules without medical supervision. Modifying meal timing alters daily insulin requirements and can increase the chance of rapid blood sugar fluctuations if medication doses remain unchanged. Patients interested in schedule adjustments need to consult their endocrinologist or primary healthcare provider.

Future clinical research will evaluate whether the 0.5 percent drop in HbA1c persists over longer periods. For now, researchers view the initial data as a foundation for evaluating meal timing as a structured adjunct alongside conventional insulin therapy.